Bay Clinical Laboratories

Bay Clinical Laboratories was paid $9.73M by Medicaid between Jan 2018 and Dec 2024, across 4 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 72% of everything it billed.

33Billing provider infoBAY CLINICAL LABORATORIES
ANNAPOLIS, MD 21401

33aNPI1376995910assigned 07/07/2016

33bProvider typeClinical Medical Laboratory

28Total paid$9.73M

24GClaims167,881

24DCodes billed4

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#6 of 93

Median peer was paid$430K

This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	38,137	$2.69M
2019	25,195	$1.51M
2020	20,805	$1.16M
2021	22,288	$1.19M
2022	21,863	$1.14M
2023	20,720	$1.08M
2024incomplete	18,873	$966K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	72%	137,954	33,710	$7.03M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	27%	29,258	13,773	$2.63M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	557	525	$69K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	112	97	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPETERSON, CHRISTINA (BILLING MANAGER)

Same official

Other billing entities under PETERSON, CHRISTINA

Full network →

Provider	Location	Paid
University Psychological Center, INC.	Baltimore, MD	$3.61M
Project Chesapeake LLC	Waldorf, MD	$1.11M
University Psychological Center, INC.	Berwyn Heights, MD	$193K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.